Genetic transfer of the wobbler gene to a C57BL/6J X NZB hybrid stock: Natural history of the motor neuron disease and response to CNTF and BDNF cotreatment

被引:14
作者
Ishiyama, T [1 ]
Klinkosz, B [1 ]
Pioro, EP [1 ]
Mitsumoto, H [1 ]
机构
[1] CLEVELAND CLIN FDN,DEPT NEUROSCI,CLEVELAND,OH 44195
关键词
D O I
10.1006/exnr.1997.6643
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Preclinical diagnosis of motor neuron disease (MND) in the wobbler mouse (wr/wr) has been impossible until recently. However, with the development of a new hybrid, the C57BL/6J x New Zealand Black (B6NZB)-wr/wr mouse, the polymerase chain reaction (PCR) can be used to establish the preclinical diagnosis. We compared the clinical and histological features of MND and the effects of neurotrophic factor cotreatment between the hybrid B6NZB-wr/wr and the congenic C57BL/6j-wr/wr mice. Clinical assessments of body weight, grip strength, running speed, paw position, and walking pattern were made weekly from age 2 weeks through 8 weeks (n = 10, B6NZB-wr/wr; n = 15, C57BL/6j-wr/wr), Survival was analyzed (n = 7, each strain) as was C5 and C6 spinal cord motoneuron morphology and ventral root histometry (n = 7, each strain). For cotreatment, 8 B6NZB-wr/wr and 7 C57BL/6J-wr/wr mice received subcutaneous ciliary neurotrophic factor (1 mg/kg) and brain-derived neurotrophic factor (5 mg/kg) on alternate days, 6 days/week for 4 weeks. B6NZB-wr/wr mice could be distinguished from C57BL/6J-wr/wr mice at age 3 weeks by a more abnormal paw position (P < 0.01) and walking pattern (P < 0.05) and lower grip strength (P < 0.001) and running speed (P < 0.001). After 3 weeks, the changes continued to be greater in B6NZB-wr/wr mice. Although B6NZB-wr/wr mice were more severely affected early in the disease, their survival was comparable to C57BL/6J-wr/wr mice, Anterior horn cell vacuolar degeneration and myelinated fiber histometry were similar in both strains. The clinical response to CNTF/BDNF cotreatment was marked in both groups although it was weaker in B6NZB-wr/wr mice. Thus, the hybrid B6NZB-wr/wr mice have a more severe clinical phenotype and offer a unique opportunity to study the mechanisms of presymptomatic motor neuron degeneration and the effects of therapeutic agents for human MND. (C) 1997 Academic Press.
引用
收藏
页码:247 / 255
页数:9
相关论文
共 26 条
[1]  
ANDREWS JM, 1974, AM J PATHOL, V76, P63
[2]   VARIANCE OF AGE AT ONSET IN A JAPANESE FAMILY WITH AMYOTROPHIC-LATERAL-SCLEROSIS ASSOCIATED WITH A NOVEL CU/ZN SUPEROXIDE-DISMUTASE MUTATION [J].
AOKI, M ;
ABE, K ;
HOUI, K ;
OGASAWARA, M ;
MATSUBARA, Y ;
KOBAYASHI, T ;
MOCHIO, S ;
NARISAWA, K ;
ITOYAMA, Y .
ANNALS OF NEUROLOGY, 1995, 37 (05) :676-679
[4]   EARLY DETECTION OF MOUSE WOBBLER MUTATION - A MODEL OF PATHOLOGICAL MOTONEURON DEATH [J].
DESPORTES, V ;
COULPIER, M ;
MELKI, J ;
DREYFUS, PA .
NEUROREPORT, 1994, 5 (15) :1861-1864
[5]   AN HEREDITARY MOTOR NEURONE DISEASE WITH PROGRESSIVE DENERVATION OF MUSCLE IN MOUSE - MUTANTWOBBLER [J].
DUCHEN, LW ;
STRICH, SJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1968, 31 (06) :535-&
[6]  
DUCHEN LW, 1966, J PHYSIOL-LONDON, V183, P53
[7]  
Falconer D., 1956, MOUSE NEWS LETT, V15, P23
[8]   EFFECTS OF BRAIN-DERIVED NEUROTROPHIC FACTOR ON MOTOR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE [J].
IKEDA, K ;
KLINKOSZ, B ;
GREENE, T ;
CEDARBAUM, JM ;
WONG, V ;
LINDSAY, RM ;
MITSUMOTO, H .
ANNALS OF NEUROLOGY, 1995, 37 (04) :505-511
[9]  
JUNIER MP, 1994, J NEUROSCI, V14, P4206
[10]   APOE-ASTERISK-4-ASSOCIATED ALZHEIMERS-DISEASE RISK IS MODIFIED BY ALPHA-1-ANTICHYMOTRYPSIN POLYMORPHISM [J].
KAMBOH, MI ;
SANGHERA, DK ;
FERRELL, RE ;
DEKOSKY, ST .
NATURE GENETICS, 1995, 10 (04) :486-488